TG Therapeutics is a American stock, trading under the symbol TGTX-Q on the NASDAQ (TGTX). It is usually referred to as NASDAQ:TGTX or TGTX-Q
In the last year, there was no coverage of TG Therapeutics published on Stockchase.
TG Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for TG Therapeutics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered TG Therapeutics In the last year. It is a trending stock that is worth watching.
On 2024-12-13, TG Therapeutics (TGTX-Q) stock closed at a price of $32.045.
Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.